News and Press Releases

Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team

To support sponsors around the globe bringing novel treatments to patients

SOUTHBOROUGH, MA – May 29, 2024 – Veristat, the Science-First...

Veristat Appoints New Chief Commercial Officer

Building on its Momentum as a Global Full-Service Clinical Research Organization (CRO) and Consultancy

Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues...

Committed  to a Science-First Approach to Support Patient Access to Life-Changing Therapies

Veristat Acquires Biometrics-focused Instat Clinical Research

Acquisition Will Power Data insights, Trial Optimization, and Value Across Clinical Development  

Veristat Acquires European Medical Writing Consultancy Scinopsis

Expands Medical Writing Team, Helping Sponsors Communicate the Value of Their Data Globally

Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation

Veristat Welcomes Three New Leaders to Executive Team, Driving Global Growth and Regulatory Success in Clinical Research

Veristat Congratulates HIPRA for EMA Approval of Its BIMERVAX® COVID-19 Vaccine

Veristat Delivered a Full Range of Clinical Trial Services Culminating in Marketing Authorization of HIPRA’s SARS-CoV-2 Vaccine and...

Veristat Supported Eight Regulatory Approvals in 2022, the Majority for Therapies Designed...

Supporting Its Continued Commitment During Rare Disease Month to Making a Difference in the Lives of Patients Faced with Limited Treatment...